21 CFR Part 11 compliant software refers to systems designed to support FDA requirements for electronic records and electronic signatures in regulated environments.
For pharmaceutical, biotech, medical device, and nutraceutical companies, maintenance, calibration, and validation records are often considered GMP records. When stored electronically, these records must meet expectations for:

21 CFR Part 11 applies when electronic systems are used to create, modify, maintain, archive, retrieve, or transmit regulated records.
For CMMS and validation tracking systems, this typically includes:
FDA investigators typically evaluate whether a system:
The FDA does not “approve” or certify software. Responsibility for compliance remains with the regulated organization.
However, selecting software designed for regulated environments significantly reduces validation burden and compliance risk.
The FDA does not certify or approve software products. Vendors provide systems designed to support regulatory requirements, but validation and compliance remain the responsibility of the regulated company.
General maintenance tools may lack audit trails, access controls, or validation documentation needed in regulated environments.
Highly configurable enterprise systems often increase validation scope and administrative burden without improving documentation integrity.
21 CFR Part 11 compliance software refers to systems designed to support FDA requirements for electronic records and electronic signatures in regulated environments.
For pharmaceutical, biotech, medical device, and nutraceutical companies, maintenance, calibration, and validation records are often considered GMP records. When stored electronically, these records must meet expectations for:
No. Part 11 does not independently require electronic signatures. When an applicable FDA regulation requires a signature and an organization uses an electronic signature, Part 11 establishes requirements for the associated electronic record and signature.
No. Part 11 generally applies when records required by an FDA regulation are maintained electronically, or when electronic signatures are used in place of required handwritten signatures. Applicability depends on the record, its intended use, and the underlying regulatory requirement.
No software product makes an organization compliant by itself. GxPReady includes technical controls designed to support Part 11 compliance, but compliance also depends on system configuration, validation, company procedures, user administration, training, and how the system is used. The GxPReady system development, turnover package and process are designed to minimize the time to compliance.
GxPReady includes a structured validation package that supports customer validation activities. Because the application is standardized and requires minimal configuration, validation is less time and resource intensive than with heavily customized enterprise systems.
GxPReady supports role-based access control, audit trails, electronic signatures, and electronic records designed to support 21 CFR Part 11 requirements. Appropriate procedures, user administration, training, and validation are also required and supported as part of the turnover process.
Yes. GxPReady maintains audit-trail information for applicable regulated records to support traceability and review of record changes. Audit trails should be reviewed and managed according to company procedures and the risk associated with the records.
Customers should define the system’s intended use, establish user roles and access, complete the required validation activities, train users, and implement appropriate procedures for system administration, electronic signatures, audit-trail review, record retention, and change control. This process is streamlined by our approach to the system design, development, documentation, and turnover process.